Related Experiment Video
Updated: Jun 17, 2026
04:48
Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Perioperative beta-blockers for vascular surgery patients
1Department of Surgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA. bbrooke1@jhmi.edu
Journal of Vascular Surgery
|December 22, 2009
Summary
Perioperative beta-blocker therapy can reduce heart attack risk in vascular surgery patients. Proper monitoring is crucial to mitigate potential adverse events during the perioperative period.
Area of Science:
- Cardiology
- Vascular Surgery
- Anesthesiology
Background:
- Perioperative beta-blocker therapy is a debated topic in high-risk surgery.
- Recent trials with diverse patient groups have questioned prior recommendations for routine use.
Purpose of the Study:
- To review evidence on perioperative beta-blocker use specifically for vascular surgery patients.
- To assess the balance between benefits and risks in this patient population.
Main Methods:
- Review of existing clinical trial data and consensus statements.
- Focus on evidence pertaining to major vascular surgery procedures.
Main Results:
- Beta-blockers appear to reduce the risk of myocardial ischemia, infarction, and cardiovascular death in high-risk vascular surgery patients.
- Concurrent risk of adverse events exists if perioperative monitoring is inadequate.
Conclusions:
- Perioperative beta-blockers remain a valuable tool for improving outcomes in high-risk vascular surgery.
- Careful patient monitoring is essential to maximize benefits and minimize risks.
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:22Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...